Showing results (41-50 of 608) with videos related to
Sort By:
Pageof 61
Bioorganic & Medicinal Chemistry Letters|June 16, 2009
The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virusChristopher McGuigan, Plinio Perrone, Karolina Madela, et al.Bio-Protocol|August 30, 2021
In vitro Assay to Assess Efficacy of Potential Antiviral Compounds against Enterovirus D68Liang Sun, Leen Delang, Carmen Mirabelli, et al.Bio-Protocol|July 21, 2021
Assessing the Efficacy of Small Molecule Inhibitors in aMouse Model of Persistent Norovirus InfectionJana Van Dycke, Johan Neyts, Joana Rocha-PereiraAntiviral Research|August 7, 2013
Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replicationYannick Debing, James Winton, Johan Neyts, et al.Antiviral Research|November 21, 2017
Rational design of antiviral drug combinations based on equipotency using HCV subgenomic replicon as an in vitro modelMohamed Mandour, Inge Vliegen, Jan Paeshuyse, et al.Biochemical Pharmacology|December 25, 2019
Antiviral drug discovery against arthritogenic alphaviruses: Tools and molecular targetsRana Abdelnabi, Sofie Jacobs, Leen Delang, et al.Antimicrobial Agents and Chemotherapy|December 30, 2015
Treatment with a Nucleoside Polymerase Inhibitor Reduces Shedding of Murine Norovirus in Stool to Undetectable Levels without Emergence of Drug-Resistant VariantsJoana Rocha-Pereira, Jana Van Dycke, Johan NeytsAntiviral Research|June 4, 2015
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistanceInge Vliegen, Jan Paeshuyse, Weidong Zhong, et al.Journal of Hepatology|June 28, 2011
In vitro selection and characterization of HCV replicons resistant to multiple non-nucleoside polymerase inhibitorsLeen Delang, Inge Vliegen, Pieter Leyssen, et al.Antiviral Research|October 29, 2011
Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymeraseLeen Delang, Mathy Froeyen, Piet Herdewijn, et al.Pageof 61